| Feature Type | Standardized | Nominal ANOVA | ||||
|---|---|---|---|---|---|---|
| mRNA | BRD8899 | CTRPv2 | pan-cancer | AAC | 0.11 | 0.006 |
| mRNA | Salubrinal | GDSC1000 | pan-cancer | AAC | 0.15 | 0.007 |
| mRNA | Doxorubicin | gCSI | pan-cancer | AAC | -0.14 | 0.01 |
| mRNA | NSC95397 | CTRPv2 | pan-cancer | AAC | 0.081 | 0.02 |
| mRNA | Fumonisin B1 | CTRPv2 | pan-cancer | AAC | 0.089 | 0.02 |
| mRNA | TGX221 | CTRPv2 | pan-cancer | AAC | 0.089 | 0.02 |
| mRNA | Zebularine | CTRPv2 | pan-cancer | AAC | 0.081 | 0.02 |
| mRNA | BRD-K63431240 | CTRPv2 | pan-cancer | AAC | -0.084 | 0.02 |
| mRNA | ABT-263 | CTRPv2 | pan-cancer | AAC | 0.083 | 0.02 |
| mRNA | tretinoin:navitoclax (4:1 mol/mol) | CTRPv2 | pan-cancer | AAC | 0.082 | 0.02 |